栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/01/10 | 1,705 | 1,741 | 1,700 | 1,725 | +25 | +1.5% | 145,000 |
2024/01/09 | 1,704 | 1,720 | 1,699 | 1,700 | -10 | -0.6% | 123,400 |
2024/01/05 | 1,713 | 1,720 | 1,694 | 1,710 | +3 | +0.2% | 148,700 |
2024/01/04 | 1,701 | 1,709 | 1,678 | 1,707 | -2 | -0.1% | 69,700 |
2023/12/29 | 1,718 | 1,726 | 1,697 | 1,709 | -9 | -0.5% | 103,300 |
2023/12/28 | 1,696 | 1,718 | 1,693 | 1,718 | +11 | +0.6% | 198,300 |
2023/12/27 | 1,700 | 1,709 | 1,695 | 1,707 | +4 | +0.2% | 80,900 |
2023/12/26 | 1,700 | 1,707 | 1,691 | 1,703 | +5 | +0.3% | 97,400 |
2023/12/25 | 1,722 | 1,723 | 1,692 | 1,698 | -21 | -1.2% | 67,900 |
2023/12/22 | 1,701 | 1,721 | 1,701 | 1,719 | +8 | +0.5% | 72,500 |
2023/12/21 | 1,706 | 1,718 | 1,701 | 1,711 | -2 | -0.1% | 82,300 |
2023/12/20 | 1,718 | 1,728 | 1,705 | 1,713 | +2 | +0.1% | 95,900 |
2023/12/19 | 1,707 | 1,718 | 1,693 | 1,711 | -2 | -0.1% | 127,700 |
2023/12/18 | 1,689 | 1,722 | 1,681 | 1,713 | +8 | +0.5% | 108,200 |
2023/12/15 | 1,734 | 1,735 | 1,698 | 1,705 | -22 | -1.3% | 160,300 |
2023/12/14 | 1,729 | 1,736 | 1,703 | 1,727 | -1 | -0.1% | 137,700 |
2023/12/13 | 1,724 | 1,740 | 1,707 | 1,728 | +21 | +1.2% | 168,200 |
2023/12/12 | 1,730 | 1,733 | 1,691 | 1,707 | -18 | -1% | 169,600 |
2023/12/11 | 1,748 | 1,748 | 1,714 | 1,725 | -3 | -0.2% | 135,500 |
2023/12/08 | 1,764 | 1,764 | 1,714 | 1,728 | -23 | -1.3% | 175,600 |
2023/12/07 | 1,749 | 1,768 | 1,743 | 1,751 | -13 | -0.7% | 119,600 |
2023/12/06 | 1,718 | 1,764 | 1,713 | 1,764 | +73 | +4.3% | 251,000 |
2023/12/05 | 1,694 | 1,704 | 1,683 | 1,691 | -10 | -0.6% | 117,800 |
2023/12/04 | 1,675 | 1,704 | 1,661 | 1,701 | +6 | +0.4% | 147,000 |
2023/12/01 | 1,680 | 1,714 | 1,680 | 1,695 | +48 | +2.9% | 283,600 |
2023/11/30 | 1,640 | 1,650 | 1,632 | 1,647 | -8 | -0.5% | 127,900 |
2023/11/29 | 1,638 | 1,664 | 1,638 | 1,655 | +11 | +0.7% | 131,500 |
2023/11/28 | 1,669 | 1,669 | 1,612 | 1,644 | -27 | -1.6% | 259,000 |
2023/11/27 | 1,665 | 1,696 | 1,665 | 1,671 | +6 | +0.4% | 195,900 |
2023/11/24 | 1,652 | 1,673 | 1,643 | 1,665 | +27 | +1.6% | 238,900 |
2023/11/22 | 1,623 | 1,650 | 1,618 | 1,638 | +28 | +1.7% | 297,800 |
2023/11/21 | 1,573 | 1,613 | 1,569 | 1,610 | +26 | +1.6% | 304,400 |
2023/11/20 | 1,559 | 1,591 | 1,556 | 1,584 | +29 | +1.9% | 275,100 |
2023/11/17 | 1,526 | 1,556 | 1,526 | 1,555 | +26 | +1.7% | 117,900 |
2023/11/16 | 1,560 | 1,564 | 1,528 | 1,529 | -26 | -1.7% | 118,500 |
2023/11/15 | 1,556 | 1,573 | 1,550 | 1,555 | ±0 | ±0% | 169,700 |
2023/11/14 | 1,558 | 1,573 | 1,533 | 1,555 | +45 | +3% | 190,500 |
2023/11/13 | 1,525 | 1,542 | 1,510 | 1,510 | -25 | -1.6% | 87,600 |
2023/11/10 | 1,536 | 1,545 | 1,522 | 1,535 | -16 | -1% | 186,100 |
2023/11/09 | 1,540 | 1,558 | 1,540 | 1,551 | +13 | +0.8% | 187,000 |
2023/11/08 | 1,528 | 1,539 | 1,516 | 1,538 | +9 | +0.6% | 368,500 |
2023/11/07 | 1,506 | 1,530 | 1,506 | 1,529 | +28 | +1.9% | 288,100 |
2023/11/06 | 1,521 | 1,525 | 1,497 | 1,501 | -11 | -0.7% | 265,200 |
2023/11/02 | 1,500 | 1,517 | 1,484 | 1,512 | +9 | +0.6% | 236,900 |
2023/11/01 | 1,505 | 1,516 | 1,492 | 1,503 | +18 | +1.2% | 336,700 |
2023/10/31 | 1,436 | 1,491 | 1,423 | 1,485 | +40 | +2.8% | 419,400 |
2023/10/30 | 1,427 | 1,452 | 1,415 | 1,445 | -5 | -0.3% | 1,318,700 |
2023/10/27 | 1,479 | 1,509 | 1,426 | 1,450 | +31 | +2.2% | 624,600 |
2023/10/26 | 1,442 | 1,444 | 1,413 | 1,419 | -22 | -1.5% | 300,400 |
2023/10/25 | 1,464 | 1,468 | 1,437 | 1,441 | -12 | -0.8% | 308,800 |
201~
250
件表示中 / 6825件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 247,900円 | +7.6% | +57.5% | 2.14% | 19.16倍 | 1.88倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 122,900円 | +197.7% | - | 0.00% | 50.22倍 | 1.60倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,700円 | +3.2% | +4.5% | 3.43% | 17.43倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 68,900円 | -3.7% | -36.7% | 2.90% | 23.37倍 | 1.53倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,000円 | - | - | 0.00% | - | 50.86倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム